Surge in Counterfeit Injectables Prompts Safety Warning from AAFPRS
The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.